Literature DB >> 1192576

Electrophysiological actions of disopyramide phosphate on canine ventricular muscle and purkinje fibers.

T Kus, B I Sasyniuk.   

Abstract

Disopyramide phosphate is a new antiarrhythmic drug that has been shown to possess significant antiarrhythmic effects in animals and man. In the present investigation, the effects of 2, 5, and 10 mug/ml of disopyramide phosphate were studied on the electrophysiological properties of canine Purkinje fibers and ventricular muscle superfused in vitro. Transmembrane action potentials were recorded from Purkinje fibers in the region of maximum action potential duration (gate), from Purkinje fibers proximal and distal to the gate, and from ventricular muscle. Disopyramide phosphate produced a concentration-dependent decrease in the slope of phase 4 diastolic depolarization of spontaneously beating Purkinje fibers. In all electrically stimulated fibers, the drug decreased the amplitude and the maximum upstroke velocity of the action potential. This depression of phase 0 characteristics was accompanied by a decrease in conduction velocity. In Purkinje fibers located at the gate, a concentration-dependent parallel shift to the right and a depression of the maximum of the membrane responsiveness curve occurred. Effects on action potential duration were variable. Repolarization was altered so that action potentials with dissimilar durations recorded from sites proximal to, at, and distal to the gate became equal. The total action potential duration and the effective refractory period of gate Purkinje fibers were prolonged, but the change in action potential duration was always greater than the change in effective refractory period so that the ratio of the change in duration to the change in refractory period was always greater than one.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1192576     DOI: 10.1161/01.res.37.6.844

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  7 in total

Review 1.  Antiarrhythmic drug classifications. A critical appraisal of their history, present status, and clinical relevance.

Authors:  S Nattel
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

2.  Effects of disopyramide on repolarisation and intraventricular conduction in man.

Authors:  K Endresen; J P Amlie; K Forfang
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 3.  [Electrophysiological classification of newer antiarrhythmic drugs (author's transl)].

Authors:  W Schmitz
Journal:  Klin Wochenschr       Date:  1980-09-15

4.  Anti-arrhythmic effects of (-)-carnitine chloride and its acetyl analogue on canine late ventricular arrhythmia induced by ligation of the coronary artery as related to improvement of mitochondrial function.

Authors:  S Imai; K Matsui; M Nakazawa; N Takatsuka; K Takeda; H Tamatsu
Journal:  Br J Pharmacol       Date:  1984-06       Impact factor: 8.739

5.  Effect of disopyramide on isolated aortic ring of the rat.

Authors:  R S de Moura; J S Lima
Journal:  Br J Pharmacol       Date:  1983-03       Impact factor: 8.739

6.  Effect of mexiletine, amiodarone and disopyramide on the excitability and refractoriness of canine cardiac fibers: possible relation to antiarrhythmic drug action and classification.

Authors:  Y Nakaya; V Elharrar; B Surawicz
Journal:  Cardiovasc Drugs Ther       Date:  1987-08       Impact factor: 3.727

7.  Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy: A Translational Study.

Authors:  Raffaele Coppini; Cecilia Ferrantini; Josè Manuel Pioner; Lorenzo Santini; Zhinuo J Wang; Chiara Palandri; Marina Scardigli; Giulia Vitale; Leonardo Sacconi; Pierluigi Stefàno; Laura Flink; Katherine Riedy; Francesco Saverio Pavone; Elisabetta Cerbai; Corrado Poggesi; Alessandro Mugelli; Alfonso Bueno-Orovio; Iacopo Olivotto; Mark V Sherrid
Journal:  JACC Basic Transl Sci       Date:  2019-10-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.